FARALLON CAPITAL MANAGEMENT, L.L.C.
Q2 2026 13F filing
Updated 83 days ago89 disclosed positions worth $21.7B
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | S STATE STR SPDR S&P 500 ETF T | $4.5B | 6.00M | 20.67% | — |
| 2 | R REVOLUTION MEDICINES INC | $2.5B | 13.55M | 11.71% | Trimmed(-0.4%) |
| 3 | E ELECTRONIC ARTS INC | $1.6B | 7.92M | 7.49% | — |
| 4 | B BRIDGEBIO PHARMA INC | $800.1M | 10.74M | 3.69% | Added(+14.7%) |
| 5 | P PROTAGONIST THERAPEUTICS INC | $778.2M | 6.35M | 3.59% | Unchanged |
| 6 | E EXELIXIS INC | $732.8M | 13.47M | 3.38% | Added(+2.7%) |
| 7 | L LIQUIDIA CORPORATION | $666.9M | 8.37M | 3.08% | Trimmed(-3.4%) |
| 8 | A AMAZON COM INC | $627.5M | 2.63M | 2.90% | Trimmed(-37.6%) |
| 9 | L LANTHEUS HLDGS INC | $619.4M | 5.58M | 2.86% | Unchanged |
| 10 | N NATERA INC | $602.2M | 2.22M | 2.78% | Trimmed(-30.8%) |
| 11 | U UNITEDHEALTH GROUP INC | $528.1M | 1.27M | 2.44% | Trimmed(-30.3%) |
| 12 | T THERMO FISHER SCIENTIFIC INC | $526M | 1.05M | 2.43% | Added(+19.0%) |
| 13 | R ROIVANT SCIENCES LTD | $506.4M | 14.31M | 2.34% | Added(+47.9%) |
| 14 | A AON PLC | $458.6M | 1.38M | 2.12% | Trimmed(-45.0%) |
| 15 | B BOSTON SCIENTIFIC CORP | $449M | 10.52M | 2.07% | Added(+40.8%) |
| 16 | A BROADCOM INC | $435.1M | 1.15M | 2.01% | Trimmed(-35.3%) |
| 17 | M MICROSOFT CORP | $415.1M | 1.11M | 1.92% | Trimmed(-52.5%) |
| 18 | T TANGO THERAPEUTICS INC | $383.8M | 12.28M | 1.77% | Added(+35.0%) |
| 19 | K KKR & CO INC | $378M | 4.12M | 1.74% | Trimmed(-11.8%) |
| 20 | S SYNOPSYS INC | $370.1M | 829.6K | 1.71% | Trimmed(-31.6%) |
| 21 | B BEAM THERAPEUTICS INC | $351.3M | 10.24M | 1.62% | Added(+1.0%) |
| 22 | C CRINETICS PHARMACEUTICALS IN | $336.4M | 8.99M | 1.55% | Added(+7.8%) |
| 23 | G GRAIL INC | $284.1M | 4.16M | 1.31% | Added(+27.9%) |
| 24 | W WABTEC | $241.2M | 894.5K | 1.11% | Trimmed(-44.4%) |
| 25 | I IMMUNOVANT INC | $223.7M | 5.80M | 1.03% | Added(+275.5%) |
| 26 | T TWIST BIOSCIENCE CORP | $219.8M | 2.14M | 1.01% | Added(+49.6%) |
| 27 | M AGIOS PHARMACEUTICALS INC | $219.6M | 5.92M | 1.01% | Added(+4.1%) |
| 28 | A ARAMARK | $206.3M | 3.63M | 0.95% | Trimmed(-40.9%) |
| 29 | B BAIDU INC | $137.6M | 1.20M | 0.63% | Added(+171.3%) |
| 30 | N NOVO-NORDISK A S | $125.6M | 2.62M | 0.58% | Added(+234.9%) |
| 31 | A ACADIA HEALTHCARE COMPANY IN | $124.6M | 4.22M | 0.57% | Added(+143.0%) |
| 32 | B BRIGHTSPRING HEALTH SVCS INC | $120.8M | 1.73M | 0.56% | Added(+7.2%) |
| 33 | A ASTRAZENECA PLC | $108.8M | 574.0K | 0.50% | Added(+153.4%) |
| 34 | J JOHNSON & JOHNSON | $103.6M | 408.0K | 0.48% | Added(+175.7%) |
| 35 | E ISHARES TR | $83.3M | 130.0K | 0.38% | — |
| 36 | S STRATEGY INC | $75.4M | 87.86M | 0.35% | Added(+122.4%) |
| 37 | P PARABILIS MEDICINES INC | $64.8M | 2.37M | 0.30% | — |
| 38 | N NOVARTIS AG | $56.9M | 363.0K | 0.26% | — |
| 39 | G GUARDANT HEALTH INC | $48.3M | 322.2K | 0.22% | Added(+3927.5%) |
| 40 | ? N/A VNET GROUP INC | $46.8M | 45.00M | 0.22% | Unchanged |
| 41 | A AVALO THERAPEUTICS INC | $46.2M | 2.50M | 0.21% | Added(+172.7%) |
| 42 | J JOYY INC | $46.1M | 699.2K | 0.21% | Added(+20.9%) |
| 43 | A ASSEMBLY BIOSCIENCES INC | $44.1M | 1.60M | 0.20% | Added(+30.7%) |
| 44 | E ENANTA PHARMACEUTICALS INC | $35.3M | 2.42M | 0.16% | Trimmed(-15.8%) |
| 45 | M MAZE THERAPEUTICS INC | $33.1M | 1.11M | 0.15% | Added(+197.0%) |
| 46 | C CG ONCOLOGY INC | $28.4M | 400.0K | 0.13% | Trimmed(-40.6%) |
| 47 | M MERCK & CO INC | $25.6M | 199.0K | 0.12% | Trimmed(-44.9%) |
| 48 | W WARBY PARKER INC | $25.1M | 828.0K | 0.12% | — |
| 49 | ? N/A PERCEPTIVE CAP SOLUTIONS COR | $24.5M | 2.25M | 0.11% | Unchanged |
| 50 | K KAILERA THERAPEUTICS INC | $24.2M | 1.10M | 0.11% | — |